WCA
BIIB icon

Westover Capital Advisors’s Biogen BIIB Stock Holding History

Westover Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,136
Closed -$296K – 78
2016
Q1 		$296K Sell
1,136
-10
-0.9% -$2.64K 0.25% 76
2015
Q4 		$351K Buy
1,146
+165
+17% +$47.4K 0.29% 75
2015
Q3 		$286K Buy
+981
New +$324K 0.25% 77

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Westover Capital Advisors's BIIB Position: Q2 2016 in Review

Westover Capital Advisors sold out of Biogen (BIIB) in Q2 2016, closing a stake of 1,136 shares — an estimated $296K sold.

Westover Capital Advisors first reported a position in BIIB in Q3 2015 and held it in 3 quarters. The position peaked at $351K in Q4 2015. 967 funds tracked by Wall St. Rank hold BIIB as of Q2 2016.

  • Westover Capital Advisors reported no remaining Biogen position as of Q2 2016 after selling out during the quarter.
  • Westover Capital Advisors sold 1,136 Biogen shares in Q2 2016, an estimated $296K.
  • Westover Capital Advisors first reported a position in Biogen in Q3 2015 and held it in 3 quarters.
  • Westover Capital Advisors's Biogen position peaked at $351K in Q4 2015.
  • 967 funds tracked by Wall St. Rank held Biogen as of Q2 2016.

Based on Westover Capital Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.